slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
167,2 EUR | +1,58% | -0,36% | +17,00% |
30/05 | Merck KGaA slaat de handen ineen met Zuid-Koreaanse universiteit om onderzoek naar biowetenschappen te ondersteunen | MT |
28/05 | MERCK KGAA : Jefferies handhaaft koopadvies | ZD |
Vakgebied
- oplossingen en producten voor wetenschappelijk en biotechnologisch onderzoek (44,2%);
- farmaceutische producten (38,4%): geneesmiddelen op recept voor de behandeling van diabetes, kanker, multiple sclerose, onvruchtbaarheid, hart- en vaatziekten, aandoeningen van het centrale zenuwstelsel, ontstekingsziekten, enz;
- hoogwaardige materialen voor de elektronica-industrie (17,4%): halfgeleidermaterialen, vloeibare kristallen, pigmenten en additieven, organische materialen op koolstofbasis, enz.
De netto-omzet is geografisch als volgt verdeeld: Duitsland (4,8%), Europa (24%), China (12,9%), Azië/Pacific (20,1%), Verenigde Staten (26,8%), Noord-Amerika (1,6%), Latijns-Amerika (6,3%), Midden-Oosten en Afrika (3,5%).
Aantal werknemers: 62 345
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Life Science
44,2
%
| 10 380 | 46,7 % | 9 281 | 44,2 % | -10,59% |
Healthcare
38,4
%
| 7 839 | 35,3 % | 8 053 | 38,4 % | +2,73% |
Electronics
17,4
%
| 4 013 | 18,1 % | 3 659 | 17,4 % | -8,82% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
28,2
%
| 6 302 | 28,3 % | 5 911 | 28,2 % | -6,20% |
Europe
21,0
%
| 4 524 | 20,3 % | 4 402 | 21,0 % | -2,70% |
Asia Pacific
19,9
%
| 4 479 | 20,1 % | 4 181 | 19,9 % | -6,65% |
China
11,8
%
| 2 818 | 12,7 % | 2 477 | 11,8 % | -12,10% |
Germany
6,8
%
| 1 532 | 6,9 % | 1 420 | 6,8 % | -7,31% |
Latin America
6,0
%
| 1 175 | 5,3 % | 1 267 | 6,0 % | +7,83% |
Middle East and Africa
2,5
%
| 516 | 2,3 % | 535 | 2,5 % | +3,68% |
Switzerland
2,4
%
| 592 | 2,7 % | 512 | 2,4 % | -13,51% |
North America
1,4
%
| 294 | 1,3 % | 287 | 1,4 % | -2,38% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 13-07-20 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01-08-14 |
Director of Finance/CFO | 54 | 26-04-19 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-19 |
Danny Bar-Zohar
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-20 |
Constantin Fest
IRC | Investor Relations Contact | - | - |
Jeff White
PRN | Corporate Officer/Principal | - | - |
Andrew Paterson
SAM | Sales & Marketing | - | - |
Corporate Officer/Principal | - | 01-09-21 | |
Hong Chow
PRN | Corporate Officer/Principal | 53 | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 75 | 09-05-14 | |
Chairman | 67 | 26-04-19 | |
Jürgen Glaser
BRD | Director/Board Member | 61 | 01-05-12 |
Alexander Putz
BRD | Director/Board Member | 47 | 01-01-85 |
Director of Finance/CFO | 54 | 26-04-19 | |
Barbara Lambert
BRD | Director/Board Member | 62 | 11-08-23 |
Sascha Held
BRD | Director/Board Member | - | 26-04-19 |
Renate Koehler
BRD | Director/Board Member | - | 26-04-19 |
Anne Lange
BRD | Director/Board Member | - | 26-04-19 |
Daniel Thelen
BRD | Director/Board Member | - | 26-04-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 305 535 626 | 0 | 0 | 29,71 % |
Aandeel B | 1 | 129 242 252 | 129 159 619 ( 99,94 %) | 0 |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
2 787 509 | 4.43% | 117 772 255 $ | |
PT MERCK TBK 86.65% | 388 194 920 | 86.65% | 97 405 869 $ |
VERA THERAPEUTICS, INC. 3.48% | 1 913 501 | 3.48% | 74 033 354 $ |
PRECIGEN, INC. 8.29% | 20 647 152 | 8.29% | 28 906 013 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Ridgefield Holdco SARL
| |
Merck Specialities Pvt Ltd.
Merck Specialities Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Specialities Pvt Ltd. is a pharmaceutical manufacturing and Indian distribution company. The company is based in Mumbai, India and was founded in 2005. |
Pharmaceuticals: Major
|
Merck Finanz SARL
Merck Finanz SARL Medical/Nursing ServicesHealth Services Part of Merck KGaA, Merck Finanz SARL is a Luxembourger company that provides healthcare, life sciences, and electronic services. The company is based in Luxembourg, Luxembourg. |
Medical/Nursing Services
|
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. |
Medical Specialties
|
Merck Electronics KGaA
| |
Merck Life Science UK Ltd.
Merck Life Science UK Ltd. Chemicals: Major DiversifiedProcess Industries Founded in 1960, Merck Life Science UK Ltd. is a subsidiary of Merck KGaA. The company is based in Gillingham, UK. The British company provides advanced chemical materials for the manufacturing of LCD panels. |
Chemicals: Major Diversified
|
Merck BV
| |
Merck Life Science A/S
Merck Life Science A/S Electronic Equipment/InstrumentsElectronic Technology Part of Merck KGaA, Merck Life Science A/S is a Danish company that provides industrial instruments for measurement. The company is located in Denmark. |
Electronic Equipment/Instruments
|
Merck Santé SASU
Merck Santé SASU Pharmaceuticals: MajorHealth Technology Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France. |
Pharmaceuticals: Major
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,05% | 9 mld. | |
+58,17% | 4,96 mld. | |
-14,94% | 4,84 mld. | |
-.--% | 3,72 mld. | |
+21,94% | 2,48 mld. | |
-26,63% | 2,19 mld. | |
+16,75% | 2,12 mld. | |
-37,97% | 1,94 mld. | |
-0,50% | 1,64 mld. |
- Beurs
- Aandelen
- Koers MRK
- Koers MRCK
- Onderneming Merck KGaA